Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study

被引:3
|
作者
Hu, Ya [1 ,2 ]
Huang, Ziyuan [1 ,2 ]
Cao, Qianqian [1 ]
Chen, Bo [1 ,2 ]
Xu, Shungang [1 ,2 ]
Qiu, Wenxian [1 ,2 ]
You, Xiaohan [1 ,2 ]
Zhang, Ji [1 ,2 ]
Chen, Chaosheng [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affifiliated Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Chron Kidney Dis, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Dept Nephrol, Affifiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
关键词
IgA nephropathy; nephrotic syndrome; proteinuria; OXFORD CLASSIFICATION;
D O I
10.1080/0886022X.2023.2267138
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Both primary IgA nephropathy (IgAN) with and without nephrotic syndrome (NS) can present massive proteinuria (24-h urinary protein >= 3.5 g/d). The clinical significance of massive proteinuria may be different in the two entities and needs further research.Methods: Data of 1870 patients with biopsy-proven IgAN in our hospital from January 2011 to December 2022 was retrospectively reviewed. A total of 242 IgAN patients with massive proteinuria were enrolled. Patients who presented with nephrotic syndrome at renal biopsy were included in the IgAN with NS cohort (IgAN-NS). The IgAN with nephrotic-range proteinuria cohort (IgAN-NR) consisted of 1:1 matched cases from the remaining according to age, gender, estimated glomerular filtration rate (eGFR) at baseline, and follow-up time. The clinical and pathological characteristics between the two cohorts were analyzed.Results: The IgAN-NS had a significantly higher proteinuria level than the IgAN-NR (p < .001). Cluster analysis revealed that proteinuria was associated with lipids in IgAN-NS, while it was associated with inflammatory indicators in IgAN-NR. When the complete remission of proteinuria (CR) was not achieved, the Kaplan-Meier analysis showed the prognosis of IgAN-NS was significantly worse than that of IgAN-NR (p = .04). Then, our GLMM model and line chart showed that the serum albumin level of the IgAN-NR was always evidently higher than that of the IgAN-NS while the significant difference in urinary albumin/creatinine ratio between the two cohorts gradually disappeared during the short-term follow-up (1 year). Moreover, the Cox regression analysis showed that the increased serum albumin was an independent protective factor for the poor outcomes (eGFR decreased from the baseline >= 30% continuously or reached end-stage renal disease [ESRD]).Conclusion: The IgAN-NS had poorer clinicopathologic manifestation than IgAN-NR, including severer massive proteinuria. When the CR was not achieved, the prognosis of IgAN-NS was inferior to that of the IgAN-NR.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Audit of Posttransplant IgA Nephropathy Treatment Strategies: Single Center Study
    Rapetskaya, Nadzeya
    Komissarov, Kirill
    Kalachyk, Aleh
    TRANSPLANTATION, 2022, 106 (09) : S324 - S324
  • [42] Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
    Bagchi, Soumita
    Mani, Kalaivani
    Swamy, Anitha
    Barwad, Adarsh
    Singh, Geetika
    Bhowmik, Dipankar
    Agarwal, Sanjay Kumar
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (06): : 1661 - 1668
  • [43] Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)
    Yamamoto, Ryohei
    Imai, Enyu
    Maruyama, Shoichi
    Yokoyama, Hitoshi
    Sugiyama, Hitoshi
    Nitta, Kosaku
    Tsukamoto, Tatsuo
    Uchida, Shunya
    Takeda, Asami
    Sato, Toshinobu
    Wada, Takashi
    Hayashi, Hiroki
    Akai, Yasuhiro
    Fukunaga, Megumu
    Tsuruya, Kazuhiko
    Masutani, Kosuke
    Konta, Tsuneo
    Shoji, Tatsuya
    Hiramatsu, Takeyuki
    Goto, Shunsuke
    Tamai, Hirofumi
    Nishio, Saori
    Shirasaki, Arimasa
    Nagai, Kojiro
    Yamagata, Kunihiro
    Hasegawa, Hajime
    Yasuda, Hideo
    Ichida, Shizunori
    Naruse, Tomohiko
    Nishino, Tomoya
    Sobajima, Hiroshi
    Tanaka, Satoshi
    Akahori, Toshiyuki
    Ito, Takafumi
    Terada, Yoshio
    Katafuchi, Ritsuko
    Fujimoto, Shouichi
    Okada, Hirokazu
    Shimura, Eiji
    Kazama, Junichiro J.
    Hiromura, Keiju
    Mimura, Tetsushi
    Suzuki, Satoshi
    Saka, Yosuke
    Sofue, Tadashi
    Suzuki, Yusuke
    Shibagaki, Yugo
    Kitagawa, Kiyoki
    Morozumi, Kunio
    Fujita, Yoshiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (06) : 526 - 540
  • [44] Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)
    Ryohei Yamamoto
    Enyu Imai
    Shoichi Maruyama
    Hitoshi Yokoyama
    Hitoshi Sugiyama
    Kosaku Nitta
    Tatsuo Tsukamoto
    Shunya Uchida
    Asami Takeda
    Toshinobu Sato
    Takashi Wada
    Hiroki Hayashi
    Yasuhiro Akai
    Megumu Fukunaga
    Kazuhiko Tsuruya
    Kosuke Masutani
    Tsuneo Konta
    Tatsuya Shoji
    Takeyuki Hiramatsu
    Shunsuke Goto
    Hirofumi Tamai
    Saori Nishio
    Arimasa Shirasaki
    Kojiro Nagai
    Kunihiro Yamagata
    Hajime Hasegawa
    Hideo Yasuda
    Shizunori Ichida
    Tomohiko Naruse
    Tomoya Nishino
    Hiroshi Sobajima
    Satoshi Tanaka
    Toshiyuki Akahori
    Takafumi Ito
    Yoshio Terada
    Ritsuko Katafuchi
    Shouichi Fujimoto
    Hirokazu Okada
    Eiji Ishimura
    Junichiro J. Kazama
    Keiju Hiromura
    Tetsushi Mimura
    Satoshi Suzuki
    Yosuke Saka
    Tadashi Sofue
    Yusuke Suzuki
    Yugo Shibagaki
    Kiyoki Kitagawa
    Kunio Morozumi
    Yoshiro Fujita
    Clinical and Experimental Nephrology, 2020, 24 : 526 - 540
  • [45] Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study
    Zhu, Bin
    Liu, Wen-Hua
    Lin, Yi
    Li, Qiang
    Yu, Dong-Rong
    Jiang, Fei
    Tang, Xuan-Li
    Du, Yuan-Yuan
    Yin, Jia-Zhen
    Li, Xian-Fa
    Zhong, Yong-Zhong
    Wang, Wen-Rong
    Sun, Yue
    Zhang, Mei-Juan
    Gao, Yuan-Cheng
    Yuan, Chen-Yi
    Zhu, Cai-Feng
    Cheng, Xiao-Xia
    AMERICAN JOURNAL OF NEPHROLOGY, 2022, 53 (06) : 455 - 469
  • [46] Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study
    Yamamoto, Ryohei
    Imai, Enyu
    Maruyama, Shoichi
    Yokoyama, Hitoshi
    Sugiyama, Hitoshi
    Nitta, Kosaku
    Tsukamoto, Tatsuo
    Uchida, Shunya
    Takeda, Asami
    Sato, Toshinobu
    Wada, Takashi
    Hayashi, Hiroki
    Akai, Yasuhiro
    Fukunaga, Megumu
    Tsuruya, Kazuhiko
    Masutani, Kosuke
    Konta, Tsuneo
    Shoji, Tatsuya
    Hiramatsu, Takeyuki
    Goto, Shunsuke
    Tamai, Hirofumi
    Nishio, Saori
    Shirasaki, Arimasa
    Nagai, Kojiro
    Yamagata, Kunihiro
    Hasegawa, Hajime
    Yasuda, Hidemo
    Ichida, Shizunori
    Naruse, Tomohiko
    Fukami, Kei
    Nishino, Tomoya
    Sobajima, Hiroshi
    Tanaka, Satoshi
    Akahori, Toshiyuki
    Ito, Takafumi
    Yoshio, Terada
    Katafuchi, Ritsuko
    Fujimoto, Shouichi
    Okada, Hirokazu
    Ishimura, Eiji
    Kazama, Junichiro James
    Hiromura, Keiju
    Mimura, Tetsushi
    Suzuki, Satashi
    Saka, Yosuke
    Sofue, Tadashi
    Suzuki, Yusuke
    Shibagaki, Yugo
    Kitagawa, Kiyoki
    Morozumi, Kunio
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1266 - 1280
  • [47] Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study
    Ryohei Yamamoto
    Enyu Imai
    Shoichi Maruyama
    Hitoshi Yokoyama
    Hitoshi Sugiyama
    Kosaku Nitta
    Tatsuo Tsukamoto
    Shunya Uchida
    Asami Takeda
    Toshinobu Sato
    Takashi Wada
    Hiroki Hayashi
    Yasuhiro Akai
    Megumu Fukunaga
    Kazuhiko Tsuruya
    Kosuke Masutani
    Tsuneo Konta
    Tatsuya Shoji
    Takeyuki Hiramatsu
    Shunsuke Goto
    Hirofumi Tamai
    Saori Nishio
    Arimasa Shirasaki
    Kojiro Nagai
    Kunihiro Yamagata
    Hajime Hasegawa
    Hidemo Yasuda
    Shizunori Ichida
    Tomohiko Naruse
    Kei Fukami
    Tomoya Nishino
    Hiroshi Sobajima
    Satoshi Tanaka
    Toshiyuki Akahori
    Takafumi Ito
    Terada Yoshio
    Ritsuko Katafuchi
    Shouichi Fujimoto
    Hirokazu Okada
    Eiji Ishimura
    Junichiro James Kazama
    Keiju Hiromura
    Tetsushi Mimura
    Satashi Suzuki
    Yosuke Saka
    Tadashi Sofue
    Yusuke Suzuki
    Yugo Shibagaki
    Kiyoki Kitagawa
    Kunio Morozumi
    Clinical and Experimental Nephrology, 2018, 22 : 1266 - 1280
  • [48] CLINICAL SIGNIFICANCE OF NEWREMISSION CRITERIA OF IGA NEPHROPATHY FOR RENAL PROGNOSIS. : A RETROSPECTIVE JAPANESE MULTICENTER LARGE COHORT STUDY
    Matsuzaki, Keiichi
    Suzuki, Yusuke
    Suzuki, Hitoshi
    Horikoshi, Satoshi
    Kawamura, Tetsuya
    Yasuda, Yoshinari
    Yasuda, Takashi
    Matsuo, Seiichi
    Maruyama, Shoichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 132 - 133
  • [49] Clinical Significance Of Urine Annexin A5 In Primary Nephrotic syndrome Of Children
    Liu, Tao
    Zhang, Bili
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1589 - 1589
  • [50] THE CLINICAL FEATURES OF SAPHO SYNDROME IN JAPANESE PATIENTS: A SINGLE CENTER COHORT STUDY
    Akiyama, Y.
    Sato, T.
    Hanai, S.
    Kamata, Y.
    Nagatani, K.
    Iwamoto, M.
    Okazaki, H.
    Minota, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 756 - 756